SyMRI to be studied as a technology to characterize brain tumors at cancer center in USA

SyntheticMR and The University of Texas MD Anderson Cancer Center have signed a research agreement to study SyMRI to characterize brain tumors.

SyMRI provides quantitative information including tissue segmentation and T1, T2 and PD-maps, thus adding objective data to the MRI exam. The technology will be studied for its potential to add diagnostic value for various clinical applications including characterization of brain tumors.

SyMRI IMAGE generates multiple contrast images from a single 3 to 6 minutes scan, thus allowing a significant reduction in scan time compared to serial acquisition of each contrast image separately. Parameters are also adjustable post scan, enabling both fine tuning of images as well as recreation of additional contrasts. SyMRI NEURO adds quantitative data and automatic segmentation of brain tissue for efficient analysis and objective decision making.

The agreement with MD Anderson includes a one year license of SyMRI IMAGE and SyMRI NEURO for research use at the hospital. For SyntheticMR, MD Anderson is an important reference site in the USA. SyMRI is CE-marked for clinical use in Europe but SyMRI is not available for clinical use in the USA.

For additional information, please contact Maria Wrethag, CMO and Head of investor relations SyntheticMR AB, +46 76 119 1983, or Stefan Tell, CEO SyntheticMR AB, +46 73 373 40 90.

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has devloped SyMRI®, delivering multiple, adjustable contrast images and quantitative data from one 3-6 minutes scan. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps™, quantitative T1, T2 and PD maps of the brain, allowing the investigation to be taken even further. SyMRI is a CE-marked product. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the AktieTorget exchange in Stockholm, Sweden. For additional information, please visit .


Documents & Links